Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
300357
Company Profile
Business description
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.
Contact
No. 636 Zhiyuan North Road
Wukang Town, Deqing County
Zhejiang Province
Huzhou313299
CHNT: +86 5728350682
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
1,679
Stocks News & Analysis
stocks
Finding yield on the ASX
The ASX, known for its yield appeal is at its lowest level in 20 years. Here’s why, and what investors should do.
stocks
ExxonMobil earnings: Continued execution, on track for 2030 targets
We’ve raised our fair value estimate of Exxon stock.
stocks
Disney earnings: No big surprises in solid results
Growth in areas critical to the firm’s future.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,149.30 | 6.90 | -0.08% |
| CAC 40 | 8,150.11 | 31.06 | -0.38% |
| DAX 40 | 24,751.91 | 45.61 | -0.18% |
| Dow JONES (US) | 49,400.46 | 7.20 | -0.01% |
| FTSE 100 | 10,288.82 | 52.74 | -0.51% |
| HKSE | 26,834.77 | 59.20 | 0.22% |
| NASDAQ | 23,329.90 | 262.21 | -1.11% |
| Nikkei 225 | 54,720.66 | 2,065.48 | 3.92% |
| NZX 50 Index | 13,421.52 | 9.08 | 0.07% |
| S&P 500 | 6,937.69 | 38.75 | -0.56% |
| S&P/ASX 200 | 8,857.10 | 9.20 | -0.10% |
| SSE Composite Index | 4,067.74 | 51.99 | 1.29% |